|
Dr. Alexander Zukiwski joined MedImmune as senior vice president clinical research in November 2007 and is assuming the role of chief medical officer. He is responsible for shaping and overseeing the company’s strategy for clinical trials of its drug candidates.
Prior to joining the company Dr. Zukiwski held several roles of increasing responsibility in support of Johnson & Johnson’s (J&J) medical affairs and clinical development functions at Johnson & Johnson Pharmaceutical Research & Development LLC (J&JPRD); Centocor R&D; and Ortho Biotech including therapeutic area head for oncology and acting head of oncology research & development. Most recently he held the position of vice president head of clinical oncology responsible for strategic oversight and portfolio management of therapeutic oncology hematology and supportive care clinical development programs for J&JPRD and Centocor’s oncology development group. Before joining J&J Dr. Zukiwski served in clinical oncology positions at pharmaceutical companies such as Hoffmann-LaRoche Glaxo Wellcome and Rhone-Poulenc Rorer.
Dr. Zukiwski holds degrees in pharmacy and medicine from the University of Alberta and the University of Calgary. He conducted his post-graduate training at St. Thomas Hospital Medical Center in Akron Ohio and the University of Texas M.D. Anderson Cancer Center. | 